Agreement between patients and physicians on scores of inflammatory bowel disease activity and burden assessed on a telemonitoring platform

References

• Yarlas A, Rubin DT, Panés J, et al. Burden of ulcerative colitis on functioning and well-being: a systematic literature review of the SF-36® health survey. J Crohns Colitis. 2018;12(5):600–609.
   PubMed Web of Science ®Google Scholar
• Kim AH, Roberts C, Feagan BG, et al. Developing a standard set of patient-centred outcomes for inflammatory bowel disease-an international, cross-disciplinary consensus. J Crohns Colitis. 2018;12(4):408–418.
   PubMedGoogle Scholar
• van der Have M, van der Aalst KS, Kaptein AA, et al. Determinants of health-related quality of life in crohn’s disease: a systematic review and meta-analysis. J Crohns Colitis. 2014;8(2):93–106.
   PubMed Web of Science ®Google Scholar
• Jowett SL, Jowett SL, Jowett SL, et al. Defining relapse of ulcerative colitis using a symptom-based activity index. Scand J Gastroenterol. 2003;38(2):164–171.
   PubMed Web of Science ®Google Scholar
• Harvey RF, Bradshaw JM. A simple index of crohn’s-disease activity. Lancet. 1980;1(8167):514.
   PubMed Web of Science ®Google Scholar
• Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43(1):29–32.
   PubMed Web of Science ®Google Scholar
• Kabar I, Husing-Kabar A, Maschmeier M, et al. Pictorial representation of illness and self measure (PRISM): a novel visual instrument to quantify suffering in liver cirrhosis patients and liver transplant recipients. Ann Transplant. 2018;23:674–680.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Sensky T, Casellas F, et al. A global, prospective, observational study measuring disease burden and suffering in patients with ulcerative colitis using the pictorial representation of illness and self-measure tool. J Crohn’s Colitis. 2020;15(2):228–237.
   Google Scholar
• Nguyen NH, Martinez I, Atreja A, et al. Digital health technologies for remote monitoring and management of inflammatory bowel disease: a systematic review. Am J Gastroenterol. 2022;117(1):78–97.
   PubMed Web of Science ®Google Scholar
• de Jong MJ, Boonen A, van der Meulen-de Jong AE, et al. Cost-effectiveness of telemedicine-directed specialized vs standard care for patients with inflammatory bowel diseases in a randomized trial. Clin Gastroenterol Hepatol. 2020;18(8):1744–1752.
   PubMed Web of Science ®Google Scholar
• de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, et al. Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. Lancet. 2017;390(10098):959–968.
   PubMed Web of Science ®Google Scholar
• Kim AH, Girgis A, Karimi N, et al. A web-based decision aid (myAID) to enhance quality of life, empowerment, decision making, and disease control for patients With ulcerative colitis: Protocol for a cluster randomized controlled trial. JMIR Res Protoc. 2020;9(7):e15994.
   PubMed Web of Science ®Google Scholar
• Davis SP, Ross MSH, Adatorwovor R, et al. Telehealth and mobile health interventions in adults with inflammatory bowel disease: a mixed-methods systematic review. Res Nurs Health. 2021;44(1):155–172.
   PubMed Web of Science ®Google Scholar
• Bonnaud G, Haennig A, Altwegg R, et al. Real-life pilot study on the impact of the telemedicine platform EasyMICI-MaMICI(®) on quality of life and quality of care in patients with inflammatory bowel disease. Scand J Gastroenterol. 2021;56(5):530–536.
   PubMed Web of Science ®Google Scholar
• Fantini MC, Biancone L, Dragoni G, et al. Telemedicine and remote screening for COVID-19 in inflammatory bowel disease patients: results From the SoCOVID-19 survey. Inflamm Bowel Dis. 2020;26(11):e134–e136.
   PubMed Web of Science ®Google Scholar
• Ankersen DV, Noack S, Munkholm P, et al. E-Health and remote management of patients with inflammatory bowel disease: lessons from Denmark in a time of need. Intern Med J. 2021;51(8):1207–1211.
   PubMedGoogle Scholar
• Marín-Jiménez I, Nos P, Domènech E, et al. Diagnostic performance of the simple clinical colitis activity index self-administered online at home by patients with ulcerative colitis: CRONICA-UC study. Am J Gastroenterol. 2016;111(2):261–268.
   PubMed Web of Science ®Google Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317(26):1625–1629.
   PubMed Web of Science ®Google Scholar
• Mocciaro F, Pecoraro GM, Di Mitri R, et al. Nurse in patients’ health status assessment: data from a pilot study assessing agreement among nurse and gastroenterologist in computing IBD-clinical scores. Dig Liver Dis. 2017;49(10):1110–1114.
   PubMedGoogle Scholar
• Echarri A, Vera I, Ollero V, et al. The Harvey-Bradshaw index adapted to a mobile application compared with in-clinic assessment: the MediCrohn study. Telemed J E Health. 2020;26(1):80–88.
   PubMed Web of Science ®Google Scholar
• Peter N, Kleinjung T, Horat L, et al. Validation of PRISM (pictorial representation of illness and self measure) as a novel visual assessment tool for the burden of suffering in tinnitus patients. Health Qual Life Outcomes. 2016;14:47.
   PubMed Web of Science ®Google Scholar
• Bennebroek Evertsz F, Nieuwkerk PT, Stokkers PC, et al. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers. J Crohns Colitis. 2013;7(11):890–900.
   PubMed Web of Science ®Google Scholar
• Lia C. Functionalities development for IBD tool, an italian web-app for inflammatory bowel disease monitoring. Polytechnic University of Turin; 2021, Turin, Italy.
   Google Scholar
• Lia C, Bonina M, Daperno M, et al. Evaluation and usage analysis of IBD tool: a telemonitoring platform for inflammatory bowel disease. ICT4AWE 2022. Online Streaming; 2022.
   Google Scholar
• Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 montreal world congress of gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5A–36A.
   PubMed Web of Science ®Google Scholar
• Sensky T, Büchi S. PRISM, a novel visual metaphor measuring personally salient appraisals, attitudes and decision-making: qualitative evidence synthesis. PLOS One. 2016;11(5):e0156284.
   PubMedGoogle Scholar
• Vermeire S, Schreiber S, Sandborn WJ, et al. Correlation between the crohn’s disease activity and Harvey-Bradshaw indices in assessing crohn’s disease severity. Clin Gastroenterol Hepatol. 2010;8(4):357–363.
   PubMed Web of Science ®Google Scholar
• Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174.
   PubMed Web of Science ®Google Scholar
• Bedossa P, Group TFMCS. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20(1):15–20.
   PubMed Web of Science ®Google Scholar
• Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: An update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160(5):1570–1583.
   PubMed Web of Science ®Google Scholar
• Larsen L, Drewes AM, Fallingborg J, et al. Touch screens as a tool in patient care in the IBD outpatient clinic. Scand J Gastroenterol. 2016;51(9):1106–1110.
   PubMed Web of Science ®Google Scholar